Baseline characteristics

Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus · Source last updated 2019-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      27

   units

   Participants

groups

1. description

   Adjuvant Radiation Therapy "Sandwiched" between Ifosfamide in Patients with Mixed Mesodermal Tumors Radiation Therapy : Ifosfamide 1.2gm/m2/day for 5 days. Mesna 400mg/IVSS bolus at each ifosfamide dosing followed by 1200mg IV divided in 3L/day x 5 days. Repeat q21 days x 3 cycles. After 3 cycles, RT. After RT, Ifosfamide 1.0gm/m2/day for 5 days. Mesna 333mg/IVSS bolus at each ifosfamide dosing followed by 1000mg IV divided in 3L/day x 5 days. Repeat q21 days x 3 cycles. Ifosfamide : Ifosfamide 1.2gm/m2/day for 5 days. Mesna 400mg/IVSS bolus at each ifosfamide dosing followed by 1200mg IV divided in 3L/day x 5 days. Repeat q21 days x 3 cycles. After 3 cycles, RT. After RT, Ifosfamide 1.0gm/m2/day for 5 days. Mesna 333mg/IVSS bolus at each ifosfamide dosing followed by 1000mg IV divided in 3L/day x 5 days. Repeat q21 days x 3 cycles.

   id

   BG000

   title

   Chemotherapy and Radiation Therapy

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            15

            value

            65

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            27

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            0

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            5

         title

         Hispanic or Latino

      2. measurements

         1. group Id

            BG000

            value

            22

         title

         Not Hispanic or Latino

      3. measurements

         1. group Id

            BG000

            value

            0

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Ethnicity (NIH/OMB)

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         title

         American Indian or Alaska Native

      2. measurements

         1. group Id

            BG000

            value

            0

         title

         Asian

      3. measurements

         1. group Id

            BG000

            value

            0

         title

         Native Hawaiian or Other Pacific Islander

      4. measurements

         1. group Id

            BG000

            value

            16

         title

         Black or African American

      5. measurements

         1. group Id

            BG000

            value

            10

         title

         White

      6. measurements

         1. group Id

            BG000

            value

            0

         title

         More than one race

      7. measurements

         1. group Id

            BG000

            value

            1

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race (NIH/OMB)

   unit Of Measure

   Participants

5. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            27

      title

      United States

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

6. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            14

      title

      Total Stage I

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            3

      title

      Total Stage II

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            7

      title

      Total Stage III

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            3

      title

      Total Stage IV

   description

   Federation of Gynecology and Obstetrics (FIGO) is a system for staging gynecologic cancer. I Malignancy of one (Ia) or both (Ib) ovaries, without ascites; 5-year survival: 60% II Malignancy of one (IIa) or both (IIb) ovaries, with pelvic extension and ascites; 5-year survival: 40% III Malignancy involves one/both ovaries, intraperitoneal metastases outside pelvis and/or positive retroperitoneal lymph nodes; 5-year survival: 5% IV Involvement of one/both ovaries with metastases and histologically confirmed extension to pleural cavity or liver; 5-year survival, 3%

   param Type

   COUNT_OF_PARTICIPANTS

   title

   FIGO Staging

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice